Author: Austin Freimuth, Messari Research Analyst; Compiler: 0xjs@金财经

DeSci is gaining widespread attention. Just this month, Binance Labs invested in BIO Protocol, CZ and Vitalik Buterin attended the DeSci event in Thailand, and ResearchHub hosted the first SciCon conference. The most notable milestone, however, was the breakout success of Pump.Science, which saw the combined market cap of its memecoins RIF and URO surge to over $350 million on November 18.

Pump.Science, announced at the Solana Breakpoint conference in September 2024, aims to accelerate breakthroughs in longevity science through gamification. It leverages rapid liquidity generation on pump.fun to raise funds and introduces its own mechanics to gamify the R&D process. Traders, known as "PHDegens," speculate on the results of experiments involving different compounds. These experiments are represented by memecoins such as RIF (rifampicin) and URO (urolithin A).

A major challenge for scientists is that the process of obtaining R&D funding is time-consuming, often at the expense of experimentation. This problem is particularly acute in areas such as longevity research, where a lack of immediate profitability leads to underfunding and slow scientific progress. Through its novel approach, Pump.Science can reduce this funding time from months to hours.

Source: DeSci Manifesto

Pump.Science works as follows:

1 , someone submits an experimental idea and provides the SOL to start the process.

2. A token was launched on pump.fun, SOL was used to create initial liquidity and funding experiments as tokens were sold at market capitalization milestones.

3. The experiment is divided into three stages: worms, flies and mice. Testing is performed at third-party laboratories Ora Biomedical and Tracked Biotechnologies.

4. Video updates will be uploaded to the platform every hour. The initial video of the first phase will be deployed once the market cap of the token exceeds $10,000.

5. PHDegens trades tokens to speculate on whether each compound can successfully extend the life of test subjects.

Currently, the experiments of RIF and URO are in the trial operation stage. The platform provides video updates and data on survival rates, movement and other metrics to guide trading decisions. No prescription required for humansCompounds such as Urolithin A can be self-administered, and the fourth phase will use wearable devices to collect data.

Source: Pump.Science X account

Next month, the team will launch 10 to 20 New tokens to expand experimentation. The ultimate goal is to develop a supplement store selling over-the-counter products based on the most promising compounds. The tokens will provide partial rights to the intellectual property, and profits from supplement sales will benefit token holders through buybacks and destruction. The team also mentioned plans to integrate AI agents and is considering establishing a science fund in partnership with Daos.Fun.

Although still in its early stages, Pump.Science is reimagining longevity R&D through gamification, sparking DeSci’s broader interest in the process.